#USA #Montgomery County #PharmaCann #Opus Consulting #Jacques Santucci

Opus Consulting Partners Appointed as Receiver for PharmaCann Maryland

In a significant development for the cannabis sector, Opus Consulting Partners, LLC, has been named as the receiver for PharmaCann Maryland, a leading firm in the cannabis industry. This appointment, announced by President Jacques Santucci, follows a request made to the Montgomery County Circuit Court by Argent Institutional Trust Company. The court case, summarized as Argent Institutional Trust Company v. PharmaCann of MD, LLC, underscores the complexities surrounding financial and operational management within companies in heavily regulated markets like cannabis.

PharmaCann, recognized as one of the largest privately owned cannabis firms in the United States, operates a state-of-the-art cultivation and processing facility alongside three retail dispensaries under the Verilife brand. Since the inception of Maryland's medical cannabis program, PharmaCann has been a key player, catering to both medical and adult-use consumers across the state. This role is particularly vital as Maryland continues to expand its cannabis legislation to meet growing consumer demand.

In stepping into their role, Opus Consulting is tasked with not only managing the day-to-day operations of PharmaCann but also directing a structured process to sell its assets. This includes overseeing the sale of licenses issued by the Maryland Cannabis Administration and other business resources. The structured sale aims to ensure an orderly auction to attract potential buyers, thereby maximizing the value for stakeholders involved. Opus has already sought court approval for the bidding procedures which will guide this sales process.

The structured bid process presents a unique opportunity for both financial and strategic buyers. Specifically, companies looking to expand their footprint within the cannabis sector or investors seeking to capitalize on operational assets might find this offering particularly attractive. The sale includes a variety of assets, from licenses and intellectual property to inventory and customer relationships.

Interested parties looking to submit a bid must first enter into a confidentiality agreement, a standard procedure designed to safeguard sensitive business information in competitive environments. Any inquiries or requests for further information can be directed to Opus Consulting or their legal counsel, Joshua Horn of Fox Rothschild LLP, who specializes in cannabis law and has been instrumental in navigating the associated legal frameworks.

About Opus Consulting Partners

Opus Consulting is widely recognized as a premier business advisory firm with a reputation for expertise in handling complex regulatory scenarios, especially within the cannabis industry. Their services range from providing fractional CFO solutions to managing receiverships and facilitating business turnarounds. The firm’s comprehensive approach helps guide clients through various stages of business development, ensuring they are well-positioned to navigate both challenges and opportunities.

About Fox Rothschild LLP

Fox Rothschild LLP, a powerhouse in the legal landscape, offers extensive legal services across various sectors, including cannabis. The firm’s Cannabis Law Practice has gained recognition for its prominent standing in U.S. law, being featured in notable rankings by Chambers Partners and The Legal 500. Joshua Horn, co-chair of this group, has been acknowledged as a top cannabis attorney and continues to play a crucial role in the industry's legal advancements.

As the restructuring process unfolds, all eyes will be on the developments at PharmaCann Maryland and Opus Consulting’s management of this significant transaction. As the cannabis market expands, the measures taken during this transition could set precedents for similar cases across the industry.